Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy

doi:10.3748/wjg.v22.i28.6484

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14125)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

2374

WORD

390

HTML

8764

Figures (1-1)

254

Tables (1-3)

183

Sum=11965

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

910

Download

1250

Sum=2160

Jul 28, 2016 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (64)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 28, 2016; 22(28): 6484-6500
Published online Jul 28, 2016. doi: 10.3748/wjg.v22.i28.6484

Open in New Tab Full Size Figure Download Figure

Figure 1 Recommended algorithm for hepatitis B virus testing and treatment in patients with hematological malignancies receiving anti-cancer therapy. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBc: Hepatitis B core antigen.

Citation: Law MF, Ho R, Cheung CK, Tam LH, Ma K, So KC, Ip B, So J, Lai J, Ng J, Tam TH. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World J Gastroenterol 2016; 22(28): 6484-6500
URL: https://www.wjgnet.com/1007-9327/full/v22/i28/6484.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i28.6484